Zoetis Inc., ZTS is in the exchange NYSE and its industry is Drugs – Generic in the sector of Healthcare. Based in USA, Zoetis Inc., ZTS has a market cap of 24378.41. Since its IPO date on the 2/1/2013, Zoetis Inc., ZTS performance year to date is 6.69%. Today Zoetis Inc., ZTS has gained -0.06%, with a current price of 50.77.
Ownership of the company is 0.01% for insider ownership while institutional ownership is 91.30%. The management of the company have seen the company have a payout ratio of 27.70%. Return of assets are at *TBA, with return on investment at 5.70%.
In terms of debt levels and profit levels, Zoetis Inc., ZTS is seeing a long-term debt/equity of *TBA. While Total debt/equity is *TBA. With a profit margin of 13.20%, this is combined with a gross margin of 64.10%, and operating margin of 20.80%. Zoetis Inc. ability to meet debt levels, with a current ratio of *TBA, while the quick ratio is *TBA.
For the last year Zoetis Inc., ZTS has seen a EPS growth of -41.90%. A performance for the year of 6.21%. The 52-week high is -2.70%, and the 52-week low is 35.68%. The average volume for Zoetis Inc., ZTS is 1911813.
With a target price of 54.33, can Zoetis Inc., ZTS reach this target? Looking at the value indicators of Zoetis Inc., ZTS. Zoetis Inc. has a P/E of 67.11 and a forward P/E of 22.02. Perhaps the more useful indicator than P/E, is PEG which has a value of 5.34. Zoetis Inc. also has a P/S and a P/B of 5.05 and 21.64 respectively. For P/cash, Zoetis Inc. has a value of *TBA, while it is *TBA for P/free cash flow.
At the current price of 50.77, Zoetis Inc. has a dividend yield of 0.75%. We see a return on equity of *TBA.
Looking more long-term Zoetis Inc., is projected to get an EPS growth for the next five years of 12.58%. In the short-term an EPS growth of 21.74% in the next year is forecasted. This is after a EPS growth of -41.90% for this year and for the last five years a 25.10% growth has been seen.